Novo Nordisk CEO: '80% of Wegovy pill customers' have never taken a GLP-1 before

Jun 9, 2026Channel
AI Analysis
Data from YouTube Data API v3Updated Just now

Video Overview

Video Details

Published1 month ago
Duration9:13
Video IDCBQg4yTTbEs
Languageen
CategoryNews & Politics
PrivacyPublic
Made for KidsNo
Video TypeRegular Video

Performance Metrics

Views785
Likes12
Comments3
Engagement Rate1.91%
Likes per 100 views1.53
Comments per 1K views3.82

Description

At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss the launch of the Wegovy pill and how it became the best prescription drug launch in history.

Related Videos

More videos from CNBC Television